Pierre Larochelle

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

Alexander A. C. Leung, Kara Nerenberg, Stella S. Daskalopoulou et al. · Canadian Journal of Cardiology · 2016 · 466 citations

Blood Pressure Monitoring, Hypertension, Blood Pressure +12

Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.

Ernesto L. Schiffrin, Li-Yuan Deng, Pierre Larochelle · Hypertension · 1994 · 264 citations

The 2013 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

Daniel G. Hackam, Robert R. Quinn, Pietro Ravani et al. · Canadian Journal of Cardiology · 2013 · 166 citations

Blood Pressure Monitoring, Hypertension, Blood Pressure +11

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study

Alberto Zanchetti, Lennart Hansson, Björn Dahlöf et al. · Journal of Hypertension · 2001 · 165 citations

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial

Sverre E. Kjeldsen, Stevo Julius, Giuseppe Mancia et al. · Journal of Hypertension · 2006 · 163 citations